These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27759594)

  • 1. The Association of Peripheral Blood Regulatory T-Cell Concentrations With Epithelial Ovarian Cancer: A Brief Report.
    Cannioto RA; Sucheston-Campbell LE; Hampras S; Goode EL; Knutson K; Ness R; Modugno F; Wallace P; Szender JB; Mayor P; Hong CC; Joseph JM; Friel G; Davis W; Nesline M; Eng KH; Edwards RP; Kruszka B; Schmitt K; Odunsi K; Moysich KB
    Int J Gynecol Cancer; 2017 Jan; 27(1):11-16. PubMed ID: 27759594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxP3+ regulatory T cells in peripheral blood of patients with epithelial ovarian cancer.
    Erfani N; Hamedi-Shahraki M; Rezaeifard S; Haghshenas M; Rasouli M; Samsami Dehaghani A
    Iran J Immunol; 2014 Jun; 11(2):105-12. PubMed ID: 24975967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer.
    Zhu Q; Wu X; Wu Y; Wang X
    Oncol Rep; 2016 Dec; 36(6):3472-3478. PubMed ID: 27748885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance.
    Winkler I; Wilczynska B; Bojarska-Junak A; Gogacz M; Adamiak A; Postawski K; Darmochwal-Kolarz D; Rechberger T; Tabarkiewicz J
    J Ovarian Res; 2015 Jun; 8():39. PubMed ID: 26077607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Th22 cells and related cytokines in patients with epithelial ovarian cancer.
    Wang T; Zhang Z; Xing H; Wang L; Zhang G; Yu N; Wang J; Guo W; Jiang J
    Medicine (Baltimore); 2017 Oct; 96(43):e8359. PubMed ID: 29069020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative deficiency in peripheral blood Vγ9Vδ2 cells is a negative prognostic biomarker in ovarian cancer patients.
    Thedrez A; Lavoué V; Dessarthe B; Daniel P; Henno S; Jaffre I; Levêque J; Catros V; Cabillic F
    PLoS One; 2013; 8(5):e63322. PubMed ID: 23717410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on early diagnosis of epithelial ovarian cancer by analysis of plasma septin-9 and clusterin level.
    Lyu N; Wang Y; Wang J; Zhang Z; Kong W
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S444-S449. PubMed ID: 29970704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.
    Hampras SS; Sucheston-Campbell LE; Cannioto R; Chang-Claude J; Modugno F; Dörk T; Hillemanns P; Preus L; Knutson KL; Wallace PK; Hong CC; Friel G; Davis W; Nesline M; Pearce CL; Kelemen LE; Goodman MT; Bandera EV; Terry KL; Schoof N; Eng KH; Clay A; Singh PK; Joseph JM; Aben KK; Anton-Culver H; Antonenkova N; Baker H; Bean Y; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Cook LS; Cramer DW; Cybulski C; Dansonka-Mieszkowska A; Dennis J; Despierre E; Dicks E; Doherty JA; du Bois A; Dürst M; Easton D; Eccles D; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Gronwald J; Harrington P; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MA; Hogdall C; Hogdall E; Hosono S; Iversen ES; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kellar M; Kelley JL; Kiemeney LA; Klapdor R; Kolomeyevskaya N; Krakstad C; Kjaer SK; Kruszka B; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Liu S; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Moes-Sosnowska J; Narod SA; Nedergaard L; Nevanlinna H; Nickels S; Olson SH; Orlow I; Weber RP; Paul J; Pejovic T; Pelttari LM; Perkins B; Permuth-Wey J; Pike MC; Plisiecka-Halasa J; Poole EM; Risch HA; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schmitt K; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Tangen IL; Teo SH; Thompson PJ; Timorek A; Tsai YY; Tworoger SS; Tyrer J; van Altena AM; Vergote I; Vierkant RA; Walsh C; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Gayther SA; Ramus SJ; Sellers TA; Schildkraut JM; Phelan CM; Berchuck A; Chenevix-Trench G; Cunningham JM; Pharoah PP; Ness RB; Odunsi K; Goode EL; Moysich KB
    Oncotarget; 2016 Oct; 7(43):69097-69110. PubMed ID: 27533245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
    Leveque L; Deknuydt F; Bioley G; Old LJ; Matsuzaki J; Odunsi K; Ayyoub M; Valmori D
    J Immunother; 2009; 32(2):101-8. PubMed ID: 19238008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sub-optimal primary surgery leads to unfavorable immunological changes in ovarian cancer patients.
    Nowak M; Głowacka E; Lewkowicz P; Banasik M; Szyłło K; Zimna K; Bednarska K; Klink M
    Immunobiology; 2018 Jan; 223(1):1-7. PubMed ID: 29017822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma immune analytes in patients with epithelial ovarian cancer.
    Block MS; Maurer MJ; Goergen K; Kalli KR; Erskine CL; Behrens MD; Oberg AL; Knutson KL
    Cytokine; 2015 May; 73(1):108-13. PubMed ID: 25743245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer.
    Knutson KL; Maurer MJ; Preston CC; Moysich KB; Goergen K; Hawthorne KM; Cunningham JM; Odunsi K; Hartmann LC; Kalli KR; Oberg AL; Goode EL
    Cancer Immunol Immunother; 2015 Dec; 64(12):1495-504. PubMed ID: 26298430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortium.
    Gostner JM; Obermayr E; Braicu IE; Concin N; Mahner S; Vanderstichele A; Sehouli J; Vergote I; Fuchs D; Zeillinger R
    Gynecol Oncol; 2018 May; 149(2):371-380. PubMed ID: 29530331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Treg cells and IDO on human epithelial ovarian cancer cells under hypoxic conditions.
    Liu J; Zhang H; Jia L; Sun H
    Mol Med Rep; 2015 Mar; 11(3):1708-14. PubMed ID: 25376937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular Endothelial Growth Factor (VEGF) Polymorphisms and Serum VEGF Levels in Women With Epithelial Ovarian Cancer, Benign Tumors, and Healthy Ovaries.
    González-Palomares B; Coronado Martín PJ; Maestro de Las Casas ML; Veganzones de Castro S; Rafael Fernández S; Vidaurreta Lázaro M; De la Orden García V; Vidart Aragon JA
    Int J Gynecol Cancer; 2017 Jul; 27(6):1088-1095. PubMed ID: 28574932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpression.
    Vermeij R; de Bock GH; Leffers N; Ten Hoor KA; Schulze U; Hollema H; van der Burg SH; van der Zee AG; Daemen T; Nijman HW
    J Immunother; 2011; 34(6):516-23. PubMed ID: 21654520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients.
    Wertel I; Surówka J; Polak G; Barczyński B; Bednarek W; Jakubowicz-Gil J; Bojarska-Junak A; Kotarski J
    Tumour Biol; 2015 Jun; 36(6):4811-7. PubMed ID: 25647263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis.
    Wang KC; Chang WH; Lee WL; Huang N; Huang HY; Yen MS; Guo CY; Wang PH
    BMC Cancer; 2014 Nov; 14():831. PubMed ID: 25403543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
    Montagnana M; Danese E; Ruzzenente O; Bresciani V; Nuzzo T; Gelati M; Salvagno GL; Franchi M; Lippi G; Guidi GC
    Clin Chem Lab Med; 2011 Mar; 49(3):521-5. PubMed ID: 21288178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of the Mac-1 expression on peripheral blood neutrophils in patients with different types of epithelial ovarian cancer.
    Bednarska K; Klink M; Wilczyński JR; Szyłło K; Malinowski A; Sułowska Z; Nowak M
    Immunobiology; 2016 Feb; 221(2):323-32. PubMed ID: 26563750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.